Detalhe da pesquisa
1.
Molecular profiling of advanced soft-tissue sarcomas: the MULTISARC randomized trial.
BMC Cancer
; 21(1): 1180, 2021 Nov 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-34740331
2.
Blood Telomere Length Changes After Ritonavir-Boosted Darunavir Combined With Raltegravir or Tenofovir-Emtricitabine in Antiretroviral-Naive Adults Infected With HIV-1.
J Infect Dis
; 218(10): 1523-1530, 2018 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-29982509
3.
Ritonavir-boosted darunavir combined with raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults infected with HIV-1: 96 week results from the NEAT001/ANRS143 randomised non-inferiority trial.
Lancet
; 384(9958): 1942-51, 2014 Nov 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-25103176
4.
Effect of HIV infection and antiretroviral therapy initiation on genome-wide DNA methylation patterns.
EBioMedicine
; 88: 104434, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36640455
5.
Inhaled ciclesonide for outpatient treatment of COVID-19 in adults at risk of adverse outcomes: a randomised controlled trial (COVERAGE).
Clin Microbiol Infect
; 28(7): 1010-1016, 2022 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-35304280
6.
Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial.
Lancet HIV
; 8(4): e197-e205, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33794182
7.
Correlation between blood telomere length and CD4+ CD8+ T-cell subsets changes 96 weeks after initiation of antiretroviral therapy in HIV-1-positive individuals.
PLoS One
; 15(4): e0230772, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32267847
8.
Body composition and adipokines changes after initial treatment with darunavir-ritonavir plus either raltegravir or tenofovir disoproxil fumarate-emtricitabine: A substudy of the NEAT001/ANRS143 randomised trial.
PLoS One
; 14(1): e0209911, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-30689664
9.
Patient Self-Reported Adherence to Ritonavir-Boosted Darunavir Combined With Either Raltegravir or Tenofovir Disoproxil Fumarate/Emtricitabine in the NEAT001/ANRS143 Trial.
J Acquir Immune Defic Syndr
; 79(4): 481-490, 2018 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-30365452
10.
Bone mineral density and inflammatory and bone biomarkers after darunavir-ritonavir combined with either raltegravir or tenofovir-emtricitabine in antiretroviral-naive adults with HIV-1: a substudy of the NEAT001/ANRS143 randomised trial.
Lancet HIV
; 2(11): e464-73, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26520926